{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:27:55Z","timestamp":1789140475795,"version":"build-2803163510"},"reference-count":26,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.3164\/jcbn.20-143","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T22:09:39Z","timestamp":1606946979000},"page":"259-263","source":"Crossref","is-referenced-by-count":13,"title":["Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study"],"prefix":"10.3164","volume":"68","author":[{"given":"Hiromitsu","family":"Ban","sequence":"first","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"},{"name":"Department of Gastroenterology, Kusatsu General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Inatomi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Murata","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Oi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Bamba","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Andoh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shiga University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer. Dig Endosc 2016; 28: 3\u201315.","DOI":"10.1111\/den.12518"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Tate DJ, Klein A, Sidhu M, et al. Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video). Gastrointest Endosc 2019; 90: 467\u2013479.e4.","DOI":"10.1016\/j.gie.2019.04.242"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Otsuka T, Sugimoto M, Ban H, et al. Severity of gastric mucosal atrophy affects the healing speed of post-endoscopic submucosal dissection ulcers. World J Gastrointest Endosc 2018; 10: 83\u201392.","DOI":"10.4253\/wjge.v10.i5.83"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Yoshizawa Y, Sugimoto M, Sato Y, et al. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to <i>Helicobacter pylori<\/i> infection, CYP2C19 genotype, and tumor location: multicenter randomized trial. Dig Endosc 2016; 28: 162\u2013172.","DOI":"10.1111\/den.12544"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Wang J, Wu Q, Yan Y, et al. Effectiveness of fibrin sealant as hemostatic technique in accelerating ESD-induced ulcer healing: a retrospective study. Surg Endosc 2020; 34: 1191\u20131199.","DOI":"10.1007\/s00464-019-06872-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kang H, Kim BJ, Choi G, Kim JG. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: a systematic review with meta-analysis. Medicine (Baltimore) 2019; 98: e15860.","DOI":"10.1097\/MD.0000000000015860"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 2007; 82: 286\u2013296.","DOI":"10.1016\/S0025-6196(11)61024-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol 2016; 51: 177\u2013194.","DOI":"10.1007\/s00535-016-1166-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol 2016; 51: 751\u2013767.","DOI":"10.1007\/s00535-016-1227-8"},{"key":"10","unstructured":"10 Ashida K, Sakurai Y, Hori T, et al. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther 2016; 43: 240\u2013251."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study. Aliment Pharmacol Ther 2015; 42: 719\u2013730.","DOI":"10.1111\/apt.13325"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Andersson K, Carlsson E. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases. Pharmacol Ther 2005; 108: 294\u2013307.","DOI":"10.1016\/j.pharmthera.2005.05.005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ohkuma K, Iida H, Inoh Y, et al. Comparison of the early effects of vonoprazan, lansoprazole and famotidine on intragastric pH: a three-way crossover study. J Clin Biochem Nutr 2018; 63: 80\u201383.","DOI":"10.3164\/jcbn.17-128"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Maruoka D, Arai M, Kasamatsu S, et al. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: a propensity score-matching analysis. Dig Endosc 2017; 29: 57\u201364.","DOI":"10.1111\/den.12705"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Tsuchiya I, Kato Y, Tanida E, et al. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: prospective randomized controlled trial. Dig Endosc 2017; 29: 576\u2013583.","DOI":"10.1111\/den.12857"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ban H, Sugimoto M, Otsuka T, et al. Letter: a potassium-competitive acid blocker vs a proton pump inhibitor for healing endoscopic submucosal dissection-induced artificial ulcers after treatment of gastric neoplasms. Aliment Pharmacol Ther 2017; 46: 564\u2013565.","DOI":"10.1111\/apt.14202"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Hirai A, Takeuchi T, Takahashi Y, et al. Comparison of the effects of vonoprazan and lansoprazole for treating endoscopic submucosal dissection-induced artificial ulcers. Dig Dis Sci 2018; 63: 974\u2013981.","DOI":"10.1007\/s10620-018-4948-0"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Ishida T, Dohi O, Yamada S, et al. Clinical outcomes of vonoprazan-treated patients after endoscopic submucosal dissection for gastric neoplasms: a prospective multicenter observation study. Digestion 2020. DOI: 10.1159\/000507807","DOI":"10.1159\/000507807"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19 Japanese Gastric Cancer AssociationJapanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2020. DOI: 10.1007\/s10120-020-01042-y","DOI":"10.1007\/s10120-020-01042-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Tatemichi M, Sasazuki S, Inoue M, Tsugane S; Japan Public Health Center Study Group. Different etiological role of <i>Helicobacter pylori<\/i> (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen. Acta Oncol 2008; 47: 360\u2013365.","DOI":"10.1080\/02841860701843035"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Takahashi K, Sato Y, Kohisa J, et al. Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers. World J Gastrointest Endosc 2016; 8: 716\u2013722.","DOI":"10.4253\/wjge.v8.i19.716"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Hung KW, Knotts RM, Faye AS, et al. Factors associated with adherence to <i>Helicobacter pylori<\/i> testing during hospitalization for bleeding peptic ulcer disease. Clin Gastroenterol Hepatol 2020; 18: 1091\u20131098 e1.","DOI":"10.1016\/j.cgh.2019.07.037"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Arkkila PE, Sepp\u00e4l\u00e4 K, Kosunen TU, et al. Eradication of <i>Helicobacter pylori<\/i> improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Am J Gastroenterol 2003; 98: 2149\u20132156.","DOI":"10.1111\/j.1572-0241.2003.07682.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kakushima N, Fujishiro M, Yahagi N, Kodashima S, Nakamura M, Omata M. <i>Helicobacter pylori<\/i> status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection. J Gastroenterol Hepatol 2006; 21: 1586\u20131589.","DOI":"10.1111\/j.1440-1746.2006.04321.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Lim JH, Kim SG, Choi J, Im JP, Kim JS, Jung HC. Risk factors of delayed ulcer healing after gastric endoscopic submucosal dissection. Surg Endosc 2015; 29: 3666\u20133673.","DOI":"10.1007\/s00464-015-4123-z"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. Diagnosis of <i>Helicobacter pylori<\/i>: what should be the gold standard? World J Gastroenterol 2014; 20: 12847\u201312859.","DOI":"10.3748\/wjg.v20.i36.12847"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/3\/68_20-143\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T03:59:38Z","timestamp":1619841578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/68\/3\/68_20-143\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.20-143","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}